A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61P 37/02 (2006.01)
Patent
CA 2627298
The invention relates to a TGF-.beta.1 inhibitor peptide which is selected from among: peptide p144 having a sequence that corresponds to SEQ ID NO: 1, peptide p17 having a sequence that corresponds to SEQ ID NO: 2, a peptide that has at least 90 % homology with said peptides, or fragments of same. The invention relates to the use of said peptide in the preparation of an immune response modulating agent.
La présente invention concerne l'utilisation d'un peptide inhibiteur du facteur TGF- ß1 sélectionné parmi le peptide p144 dont la séquence correspond à SEQ ID NO:1, le peptide p17 dont la séquence correspond à SEQ ID NO:2, un peptide qui présente une homologie d'au moins 90 % avec ces peptides, ou des fragments de ces peptides, dans la préparation d'un agent modulateur de la réponse immunitaire.
Borras Cuesta Francisco
Casares Agar Noelia
Dotor de Las Herrerias Javier
Gil Guerrero Lucia
Lasarte Sagastibelza Juan Jose
Perry + Currier
Proyecto de Biomedicina Cima S.l.
LandOfFree
Use of tgf-.beta.1 inhibitor peptides in the preparation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tgf-.beta.1 inhibitor peptides in the preparation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tgf-.beta.1 inhibitor peptides in the preparation of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1880921